HIC1、HOXA9基因启动子甲基化在卵巢癌早期诊断中的意义的开题报告

精品文档---下载后可任意编辑HIC1、HOXA9 基因启动子甲基化在卵巢癌早期诊断中的意义的开题报告摘要：卵巢癌是女性常见的恶性肿瘤之一，具有隐匿性、失代偿性、亚型性、易转移等特点，导致晚期发现率较高，治疗难度大。因此，讨论卵巢癌早期诊断的标志物对于提高卵巢癌的早期发现率和治疗效果具有重要意义。目前，许多讨论表明，甲基化是卵巢癌发病过程中的一个重要机制，其中 HIC1 和 HOXA9 基因启动子甲基化在卵巢癌早期诊断中具有重要的意义。本文将介绍 HIC1 和 HOXA9 基因启动子甲基化在卵巢癌早期诊断中的意义。关键词：卵巢癌；HIC1；HOXA9；甲基化；早期诊断Abstract:Ovarian cancer is one of the common malignant tumors in women, with the characteristics of concealment, loss of compensation, subtype and easy metastasis, resulting in a higher rate of late detection and difficulty in treatment. Therefore, studying the biomarkers of early diagnosis of ovarian cancer is of great significance to improve the early detection rate and treatment effect of ovarian cancer. At present, many studies have shown that methylation is an important mechanism in the development of ovarian cancer, and the methylation of HIC1 and HOXA9 gene promoters are important in the early diagnosis of ovarian cancer.This article will introduce the significance of HIC1 and HOXA9 gene promoter methylation in early diagnosis of ovarian cancer.Keywords: ovarian cancer; HIC1; HOXA9; methylation; early diagnosis